FDA Drug Safety Oversight Board Will Include VA, Other Agencies
This article was originally published in The Pink Sheet Daily
Executive Summary
The panel is the primary feature of FDA's proposal to reform drug safety review within the agency; other features include the creation of a drug safety website. The panel and website are intended to increase drug safety "oversight" and "openness" at FDA.
You may also be interested in...
FDA's Drug Safety Oversight Board Looks To Promote Its Value
FDA's Drug Safety Oversight Board is trying to promote its value to the medical and regulatory communities by highlighting its role in addressing postmarketing safety issues
FDA's Drug Safety Oversight Board Looks To Promote Its Value
FDA's Drug Safety Oversight Board is trying to promote its value to the medical and regulatory communities by highlighting its role in addressing postmarketing safety issues
Drug Safety Oversight Efforts Paying Off, CDER’s Galson Says
The agency has held 29 advisory committee meetings on drug safety since February 2005, according to the CDER director.